Vaccinated Yet Booster-Hesitant: Perspectives from Boosted, Non-Boosted, and Unvaccinated Individuals

Author:

Lin Cheryl1,Bier Brooke1,Tu Rungting2ORCID,Paat John J.3,Tu Pikuei1

Affiliation:

1. Policy and Organizational Management Program, Duke University, Durham, NC 27708, USA

2. Department of Business Administration, Tunghai University, Taichung 40704, Taiwan

3. Department of Medicine, Duke University, Durham, NC 27708, USA

Abstract

Though available for all age groups in the US, only about half of those vaccinated have obtained a COVID-19 booster. Similar to the unvaccinated, those vaccinated-but-not-boosted may reduce the effectiveness of widespread viral protection. Booster hesitancy differs from general vaccine hesitancy yet remains less researched. We examined booster perceptions across vaccination status using qualitative methodologies. Four focus groups and 11 individual interviews (total n = 32) revealed nuanced changes and differences compared to the first-dose decision. Booster hesitancy stemmed from questions and surprises. Most vaccinated participants accepted the booster, though to varying degrees: enthusiastically with feelings of appreciation and added confidence, passively as an intuitive next step, indifferently following recommendation—“primed” by the yearly flu shot, and reluctantly with worries. The vaccinated-but-not-boosted group expressed confusion about the need for a new shot and discontentment as to why it was not communicated from the start, which coincided with their uncertainty about ending the pandemic. Inadvertently, booster recommendations further polarized non-vaccinated participants, augmenting their skepticism of the original dosages’ efficacy or necessity and intensifying their distrust of the government. The findings illuminate the need for adjusting vaccination promotions to better tailor communications (e.g., distinguishing its benefits from the first vaccine and emphasizing the continued risk of COVID-19 spread). Future researchers should further explore the vaccine-accepting-yet-booster-hesitant groups’ motivations and risk perceptions to reduce booster rejection.

Funder

Duke University Bass Connections

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology

Reference51 articles.

1. (2022, October 25). COVID-19 Vaccinations in the United States, Available online: https://covid.cdc.gov/COVID-data-tracker/#vaccinations_vacc-people-additional-dose-totalpop.

2. (2022, October 25). U.S. COVID-19 Map: What Do the Trends Mean for You?. Available online: https://www.mayoclinic.org/coronavirus-covid-19/map.

3. Klugar, M., Riad, A., Mohanan, L., and Pokorná, A. (2021). COVID-19 Vaccine Booster Hesitancy (VBH) of Healthcare Workers in Czechia: National Cross-Sectional Study. Vaccines, 9.

4. Kimball, S. (2022, January 17). Omicron Makes up 95% of Sequenced COVID Cases in U.S. as Infections Hit Pandemic Record. Available online: https://www.cnbc.com/2022/01/04/omicron-makes-up-95percent-of-sequenced-covid-cases-in-us-as-infections-hit-pandemic-record.html.

5. Mueller, B. (New York Times, 2022). Another COVID Surge May Be Coming. Are We Ready for It?, New York Times.

Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3